Exchange: NASDAQ·Updated 07:30 PM EDT
BLTE logo

BLTE Belite Bio Inc

$161.68
$2.81
(1.77%)
Today
Closed $161.68
$0.00
(0.00%)
After Hours
Reported EarningsAug 13
Mkt Cap$6.51B
Vol61,860.00

About BLTE

Belite Bio, Inc. engages in the research and development of drugs. It focuses on the treatment of eye diseases involving retinal degeneration such as atrophic age-related macular degeneration and autosomal recessive Stargardt disease. It also caters to metabolic diseases such as non-alcoholic fatty liver disease, nonalcoholic steatohepatitis, type 2 diabetes, and gout. The company was founded by Yu-Hsin Lin on March 27, 2018 and is headquartered in San Diego, CA.
50

Neutral Sentiment

How do you feel about BLTE?

Advertisement|Remove ads.